GE to sell #biotech business to Danaher Corp. for $21B in Q4 '19. Accroding to a release, GE plans to use the "proceeds from the transaction to reduce leverage and strengthen its balance sheet." Track GE mentions of biotech here: https://bit.ly/2GLv7NC pic.twitter.com/PDj5m0csTg
6:52 AM - 26 Feb 2019
0 replies
0 retweets
2 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.